Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

16 years and 3 Texas two-steps later, JNJ's talc lawsuit awaits key ruling
BioSpace
Wednesday, March 12, 2025 - 11:18am
tags:
JNJ, legal
Insilico Medicine raises $110M for new trials and robotic helping hands
Fierce Biotech
Wednesday, March 12, 2025 - 11:15am
tags:
Insilico, lab robotics, artificial intelligence, funding
India's Zydus Lifesciences to buy 86% stake in French medical devices maker
Yahoo/Reuters
Wednesday, March 12, 2025 - 11:13am
tags:
Zydus, M&A, Amplitude Surgical, Medtech, India
IRA reforms, including a small molecule fix, could be on the table. Will Trump and the GOP make the leap?
Pharma Voice
Wednesday, March 12, 2025 - 11:10am
tags:
Inflation Reduction Act, Donald Trump, Medicare, drug pricing
Roche builds in obesity with $5.3bn Zealand licensing deal
Pharmaphorum
Wednesday, March 12, 2025 - 11:09am
tags:
Roche, obesity, Zealand Pharma, petrelintide
Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer
Fierce Biotech
Wednesday, March 12, 2025 - 11:08am
tags:
Ono Pharmaceutical, Ionis Pharmaceuticals, antisense, sapablursen, polycythemia vera
A once-yearly PrEP? Gilead's lenacapavir shows promise as company plots phase 3
Fierce Pharma
Tuesday, March 11, 2025 - 7:10pm
tags:
Gilead Sciences, lenacapavir, HUV, PrEP
FDA reviewers, inspectors, and investigators excluded from $25K buyout offer
RAPS.org
Tuesday, March 11, 2025 - 7:07pm
tags:
HHS, FDA, drug reviewers
As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first year as CEO
Fierce Pharma
Tuesday, March 11, 2025 - 7:03pm
tags:
AbbVie, Humira, Robert Michael, Pharma CEOs, executive compensation
Merck prevails in US safety litigation over Gardasil HPV vaccine
Investing.com
Tuesday, March 11, 2025 - 7:02pm
tags:
Merck, Gardasil, vaccines, HPV, cervical cancer, legal
Women spent $8.8B more than men on medications in 2024: 4 takeaways
Beckers Hospital Review
Tuesday, March 11, 2025 - 6:59pm
tags:
Women's Health, drug spending, GoodRx
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
Drugs.com
Tuesday, March 11, 2025 - 6:57pm
tags:
Biogen, clinical trials, felzartamab, kidney translants
2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M
BioPharma Dive
Tuesday, March 11, 2025 - 11:33am
tags:
2seventy bio, Bluebird Bio, Bristol Myers Squibb, cell therapy, M&A
Viking secures 1b supply of obesity pill candidate with $150m prepayment deal
BioSpace
Tuesday, March 11, 2025 - 11:32am
tags:
Viking Therapeutics, obesity, VK2735
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle
Medtech Dive
Tuesday, March 11, 2025 - 11:25am
tags:
Orthofix Medical, legal, Medtech
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Fierce Biotech
Tuesday, March 11, 2025 - 11:23am
tags:
Daiichi Sankyo, RNA, Nosis Biosciences, drug delivery, artificial intelligence
By exercising long-held stock options, BioNTech CEO scored €260M payday in 2024
Fierce Pharma
Tuesday, March 11, 2025 - 11:17am
tags:
BioNTech, Pharma CEOs, executive compensation
Merck Opens Vaccine Manufacturing Facility in North Carolina
US News and World Report
Tuesday, March 11, 2025 - 11:14am
tags:
Merck, vaccines, North Carolina, drug manufacturing, tariffs
J&J and Protagonist’s icotrokinra scores in Phase IIb UC study
Clinical Trials Arena
Tuesday, March 11, 2025 - 11:13am
tags:
JNJ, Protagonist Therapeutics, ulcerative colitis, clinical trials, icotrokinra
The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep
Pharma Voice
Tuesday, March 11, 2025 - 11:07am
tags:
Emalex Biosciences, FDA, Tourette syndrome, ecopipam

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.